Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated Drugs:
    Austria Bulgaria Germany Hungary Poland Romania +2
  • Study of Monalizumab for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Haploidentical Transplantation

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Midostaurin and Gemtuzumab Ozogamicin for Adults with Acute Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Germany
  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark Finland The Netherlands Norway Spain +1
  • Study on Fludarabine, Melphalan, and Radiation for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Preparing for Stem Cell Transplant.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study on Cyclophosphamide and Etoposide with Radiation for High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Preparing for Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain Sweden
  • Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Austria Denmark Germany Italy The Netherlands Spain
  • Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

    Recruiting

    3 1 1
    Poland
  • Study on Adding Sulfasalazine, Idarubicin, and Cytarabine to Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia in Patients Aged 60 and Older

    Recruiting

    1 1 1 1
    Investigated Diseases:
    France